Cargando…
Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies
SIMPLE SUMMARY: The aim of the present work was to systematically review and meta-analysis the available evidence regarding the effects of oral contraceptives using on breast cancer risk in BRCA germline mutations. The included studies were published between 2002 and 2021. Data were pooled from nine...
Autores principales: | Barańska, Agnieszka, Kanadys, Wiesław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564239/ https://www.ncbi.nlm.nih.gov/pubmed/36230696 http://dx.doi.org/10.3390/cancers14194774 |
Ejemplares similares
-
Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020
por: Barańska, Agnieszka, et al.
Publicado: (2021) -
Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies
por: Barańska, Agnieszka, et al.
Publicado: (2022) -
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
por: Whittemore, A S, et al.
Publicado: (2004) -
Oral Contraceptive Use in BRCA1 and BRCA2
Mutation Carriers: Absolute Cancer Risks and Benefits
por: Schrijver, Lieske H, et al.
Publicado: (2022) -
Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review
por: Huber, D., et al.
Publicado: (2020)